Skip to search formSkip to main contentSkip to account menu

Nephroprotective Agent

Known as: Nephroprotective Agents 
Agents administered before, with, or after cancer therapy to reduce or prevent damage or toxicity to the kidney. (NCI)
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2020
Review
2020
A kidney is particularly prone to the action of nephrotoxins because it receives 25% of the cardiac output. The presence of the… 
2018
2018
BackgroundOur team has identified 17 Boreal forest species from the traditional pharmacopeia of the Eastern James Bay Cree that… 
2018
2018
Abstract Although previous studies have reported the protective effect of glucagon-like peptide-1 (GLP-1) in diabetes nephropathy… 
2016
2016
Background: Drug-induced kidney disease constitutes an important cause of acute renal failure. Recent studies indicate that free… 
Review
2014
Review
2014
The physiological hydroelectrolytic balance and the redox steady state in the kidney are accomplished by an intricate interaction… 
2014
2014
The present study aimed to evaluate the nephroprotective effects of different doses of aqueous extract of Foeniculum vulgare… 
Review
2011
Review
2011
Erythropoietin is a 30.4 kDa glycoprotein produced by the kidney, which is mostly known for its physiological function in… 
2009
2009
Kidney Disease is an increasingly common condition with limited treatment options placing a major financial and emotional burden…